Incyte Corporation

Incyte Corporation - Current Ratioverified

INCY

Price:

$98.22

Market Cap:

$19.62B

Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. Beyond its marketed drugs, Incyte's pipeline features several promising candidates. Among its clinical-stage assets are ruxolitinib, targeting steroid-refractory chronic graft-versus-host dis...[Read more]

Industry

Biotechnology

IPO Date

1993-11-04

Stock Exchange

NASDAQ

Ticker

INCY

The Current Ratio as of June 2026 (TTM) for Incyte Corporation (INCY) is 3.68

According to Incyte Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.68. This represents a change of 12.91% compared to the average of 3.26 of the last 4 quarters.

Incyte Corporation (INCY) Historical Current Ratio (quarterly & annually)

How has INCY Current Ratio performed in the past?

The mean historical Current Ratio of Incyte Corporation over the last ten years is 3.67. The current 3.68 Current Ratio has changed 9.92% with respect to the historical average. Over the past ten years (40 quarters), INCY's Current Ratio was at its highest in in the June 2019 quarter at 5.61. The Current Ratio was at its lowest in in the September 2024 quarter at 1.87.

Quarterly (TTM)
Annual

Average

3.67

Median

3.69

Minimum

1.97

Maximum

4.83

Incyte Corporation (INCY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Incyte Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 68.07%

Maximum Annual Current Ratio = 4.83

Minimum Annual Increase = -47.32%

Minimum Annual Current Ratio = 1.97

Quarterly (TTM)
Annual
YearCurrent RatioChange
20253.3268.07%
20241.97-47.32%
20233.755.88%
20223.54-3.10%
20213.65-2.36%
20203.74-22.66%
20194.8312.20%
20184.317.48%
20174.0110.28%
20163.64-27.50%

Incyte Corporation (INCY) Average Current Ratio

How has INCY Current Ratio performed in the past?

The current Current Ratio of Incyte Corporation (INCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.01

5-year avg

3.24

10-year avg

3.67

Incyte Corporation (INCY) Current Ratio vs. Peers

How is INCY’s Current Ratio compared to its peers?

Incyte Corporation’s Current Ratio is less than United Therapeutics Corporation (4.79), greater than Genmab A/S (2.18), greater than Royalty Pharma plc (2.66), greater than Quest Diagnostics Incorporated (1.18), greater than Zimmer Biomet Holdings, Inc. (1.73), greater than West Pharmaceutical Services, Inc. (2.71), greater than Waters Corporation (1.79), greater than Biogen Inc. (3.06), greater than Illumina, Inc. (1.75), greater than Tenet Healthcare Corporation (1.36),

Build a custom stock screener for Incyte Corporation (INCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Incyte Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Incyte Corporation (INCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Incyte Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Incyte Corporation's Current Ratio?

How is the Current Ratio calculated for Incyte Corporation (INCY)?

What is the highest Current Ratio for Incyte Corporation (INCY)?

What is the 3-year average Current Ratio for Incyte Corporation (INCY)?

What is the 5-year average Current Ratio for Incyte Corporation (INCY)?

How does the current Current Ratio for Incyte Corporation (INCY) compare to its historical average?